全文获取类型
收费全文 | 62595篇 |
免费 | 4404篇 |
国内免费 | 1449篇 |
专业分类
耳鼻咽喉 | 169篇 |
儿科学 | 1437篇 |
妇产科学 | 774篇 |
基础医学 | 4577篇 |
口腔科学 | 547篇 |
临床医学 | 7748篇 |
内科学 | 19741篇 |
皮肤病学 | 297篇 |
神经病学 | 1028篇 |
特种医学 | 941篇 |
外国民族医学 | 1篇 |
外科学 | 7382篇 |
综合类 | 9799篇 |
现状与发展 | 3篇 |
预防医学 | 3349篇 |
眼科学 | 146篇 |
药学 | 5688篇 |
53篇 | |
中国医学 | 3198篇 |
肿瘤学 | 1570篇 |
出版年
2024年 | 120篇 |
2023年 | 1118篇 |
2022年 | 1979篇 |
2021年 | 2839篇 |
2020年 | 2724篇 |
2019年 | 2249篇 |
2018年 | 2152篇 |
2017年 | 2138篇 |
2016年 | 2144篇 |
2015年 | 2300篇 |
2014年 | 4470篇 |
2013年 | 4590篇 |
2012年 | 3523篇 |
2011年 | 4171篇 |
2010年 | 3153篇 |
2009年 | 3100篇 |
2008年 | 3026篇 |
2007年 | 3090篇 |
2006年 | 2784篇 |
2005年 | 2506篇 |
2004年 | 1937篇 |
2003年 | 1703篇 |
2002年 | 1386篇 |
2001年 | 1292篇 |
2000年 | 958篇 |
1999年 | 855篇 |
1998年 | 684篇 |
1997年 | 637篇 |
1996年 | 604篇 |
1995年 | 519篇 |
1994年 | 532篇 |
1993年 | 370篇 |
1992年 | 330篇 |
1991年 | 327篇 |
1990年 | 283篇 |
1989年 | 288篇 |
1988年 | 273篇 |
1987年 | 193篇 |
1986年 | 168篇 |
1985年 | 170篇 |
1984年 | 151篇 |
1983年 | 79篇 |
1982年 | 103篇 |
1981年 | 86篇 |
1980年 | 73篇 |
1979年 | 72篇 |
1978年 | 52篇 |
1977年 | 40篇 |
1976年 | 43篇 |
1974年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
42.
43.
44.
目的探讨支气管哮喘患儿中性粒细胞胞外诱捕网水平与患者免疫功能及临床预后的关系。方法选取本院2017年9月-2018年9月支气管哮喘患者80例作为观察组,并以同期健康体检的30例儿童作为对照组,采用pico Green dsDNA荧光染色定量检测支气管哮喘患者NETs水平,采用T淋巴细胞亚群评价患者免疫功能,对比不同NETs水平患者免疫功能及临床特点,采用Logistic回归分析探讨小儿支气管哮喘急性发作的风险因素。结果观察组白细胞、中性粒细胞、单核细胞、Cf-DNA/NETs水平均高于对照组(P <0. 05),而淋巴细胞水平低于对照组,差异均有统计学意义(P <0. 05)。Logistic回归分析显示,哮喘家族史、呼吸道感染、Cf-DNA/NETs水平上升、有害气体接触、被动吸烟均是支气管哮喘急性发作的独立危险因素(P <0. 05)。结论中性粒细胞胞外诱捕网水平与支气管哮喘患者免疫功能及预后密切相关,值得临床重点关注。 相似文献
45.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。 相似文献
46.
Altan Ahmed John A. Stauffer Jordan D. LeGout Justin Burns Kristopher Croome Ricardo Paz-Fumagalli Gregory Frey Beau Toskich 《Journal of gastrointestinal oncology.》2021,12(2):751
BackgroundNeoadjuvant yttrium-90 transarterial radioembolization (TARE) is increasingly being used as a strategy to facilitate resection of otherwise unresectable tumors due to its ability to generate both tumor response and remnant liver hypertrophy. Perioperative outcomes after the use of neoadjuvant lobar TARE remain underinvestigated.MethodsA single center retrospective review of patients who underwent lobar TARE prior to major hepatectomy for primary or metastatic liver cancer between 2007 and 2018 was conducted. Baseline demographics, radioembolization parameters, pre- and post-radioembolization volumetrics, intra-operative surgical data, adverse events, and post-operative outcomes were analyzed.ResultsTwenty-six patients underwent major hepatectomy after neoadjuvant lobar TARE. The mean age was 58.3 years (17–88 years). 62% of patients (n=16) had primary liver malignancies while the remainder had metastatic disease. Liver resection included right hepatectomy or trisegmentectomy, left or extended left hepatectomy, and sectorectomy/segmentectomy in 77% (n=20), 8% (n=2), and 15% (n=4) of patients, respectively. The mean length of stay was 8.3 days (range, 3–33 days) and there were no grade IV morbidities or 90-day mortalities. The incidence of post hepatectomy liver failure (PHLF) was 3.8% (n=1). The median time to progression after resection was 4.5 months (range, 3.3–10 months). Twenty-three percent (n=6) of patients had no recurrence. The median survival was 28.9 months (range, 16.9–46.8 months) from major hepatectomy and 37.6 months (range, 25.2–53.1 months) from TARE.ConclusionsMajor hepatectomy after neoadjuvant lobar radioembolization is safe with a low incidence of PHLF. 相似文献
47.
48.
ObjectivesLaryngeal cancer is a common malignant tumor that originates from the larynx, yet its molecular mechanisms have not been thoroughly explored. The purpose of this study was to identify and evaluate immune-related genes in laryngeal cancer through gene co-expression networks, which may serve as biomarkers for its immunotherapy.MethodsWe applied ESTIMATE to evaluate the immune-infiltration landscape of tumor microenvironment. The co-expression networks were constructed by weighted gene co expression network analysis (WGCNA) and compared with the existing human immune related genes (IRGs) to determine the co-expressed IRGs. GSVA combined with CIBERSORT and ssGSEA illustrated the correlation of hub genes and immune infiltration patterns. TIDE algorithm and Subclass mapping evaluated the function of hub genes in predicting immune function and immunotherapeutic sensitivity. The pRRophetic was employed in the sensitivity prediction of chemotherapeutic drugs.ResultsA total of 23 co-expressed IRGs were identified and showed robust expression characteristics. These genes were significantly related to immune infiltration patterns, immune function and sensitivity prediction of immunotherapy and chemotherapeutic drugs for laryngeal cancer patients. Genetic alteration in somatic mutation level and related pathways were also revealed.ConclusionThe 23 co-expressed IRGs may act as immunotherapeutic biomarkers and potential therapeutic targets for laryngeal cancer with certain expression robustness. The molecular mechanisms deserve further investigation, which will guide clinical treatment in the future. 相似文献
49.
50.